Patent: 10,010,400
✉ Email this page to a colleague
Summary for Patent: 10,010,400
| Title: | Devices and methods for local delivery of drug to upper urinary tract |
| Abstract: | Drug delivery devices include a flexible elongate body having a bladder end portion, a kidney end portion, and a drug lumen extending therebetween; and a drug reservoir which is located at the bladder end portion, contains a drug, and is defined at least in part by a semi-permeable wall. Methods include inserting the device into the ureter of a patient and permitting water in the bladder to diffuse through the semi-permeable wall to create an osmotic pressure to pump the drug through the drug lumen and out of the device at the kidney end portion and into the renal pelvis. |
| Inventor(s): | Lee; Heejin (Bedford, MA), Larrivee-Elkins; Cheryl (Framingham, MA), Ho Duc; Hong Linh (Weston, MA), Mixter; Colin (Exeter, NH) |
| Assignee: | TARIS Biomedical LLC (Lexington, MA) |
| Application Number: | 15/085,179 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,010,400
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2035-03-30 |
| Clinigen, Inc. | PROLEUKIN | aldesleukin | For Injection | 103293 | 05/05/1992 | ⤷ Try a Trial | 2035-03-30 |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2035-03-30 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
